Management of paediatric tuberculosis in provincial and district hospitals in Afghanistan

Insights

Diagnosing and treating childhood tuberculosis (TB) in Afghanistan faces significant challenges. Improvements are needed in TB case detection, diagnosis, and contact management within the national TB program.

Area of Science:

  • Pediatric Infectious Diseases
  • Public Health
  • Global Health

Background:

  • Childhood tuberculosis (TB) diagnosis and management present global challenges.
  • Afghanistan's national TB program aims to improve pediatric TB care, including contact tracing.
  • Limited data exists on the effectiveness of current pediatric TB case management strategies in Afghanistan.

Purpose of the Study:

  • To evaluate the current state of pediatric TB case management in Afghanistan.
  • To identify key challenges in diagnosis, treatment, and contact investigation for childhood TB.
  • To provide recommendations for enhancing the national TB program's approach to pediatric TB.

Main Methods:

  • A retrospective review of pediatric TB case management documents was conducted.
  • Data was collected from 15 district hospitals and 8 provincial hospitals across 7 regions of Afghanistan.
  • Key performance indicators included suspect rates, diagnostic test utilization, treatment adherence, and contact management coverage.

Main Results:

  • A low outpatient suspect rate of 0.4% was observed, particularly low in children under 5 years.
  • Suspect management yielded low performance, with only 68.5% of suspects receiving further examinations.
  • Low utilization of diagnostic methods, a high early defaulter rate (14.0%), and insufficient contact management coverage (74.0%) were noted.

Conclusions:

  • Afghanistan's national TB program requires strategic planning to improve pediatric TB diagnosis quality.
  • Enhancing suspect management and diagnostic test utilization is crucial for effective childhood TB case finding.
  • Improving contact management coverage is essential to curb TB transmission in pediatric populations.

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
984
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
810
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.7K
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
1.7K
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
2.4K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
401